Next Century Growth Investors’s Outset Medical OM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
Sell
-22,219
Closed -$3.63M 125
2023
Q3
$3.63M Sell
22,219
-9,596
-30% -$2.26M 0.39% 70
2023
Q2
$10.4M Sell
31,815
-4,599
-13% -$1.4M 1.01% 34
2023
Q1
$10.1M Buy
36,414
+4,387
+14% +$1.61M 1.11% 33
2022
Q4
$12.4M Sell
32,027
-13,131
-29% -$3.7M 1.49% 23
2022
Q3
$10.8M Buy
45,158
+28,010
+163% +$7.5M 1.32% 30
2022
Q2
$3.82M Buy
+17,148
New +$7.38M 0.5% 55

Other funds holding OM

Next Century Growth Investors's OM Position: Q4 2023 in Review

Next Century Growth Investors sold out of Outset Medical (OM) in Q4 2023, closing a stake of 22,219 shares — an estimated $3.63M sold.

Next Century Growth Investors first reported a position in OM in Q2 2022 and held it in 6 quarters. The position peaked at $12.4M in Q4 2022. 140 funds tracked by Wall St. Rank hold OM as of Q4 2023.

  • Next Century Growth Investors reported no remaining Outset Medical position as of Q4 2023 after selling out during the quarter.
  • Next Century Growth Investors sold 22,219 Outset Medical shares in Q4 2023, an estimated $3.63M.
  • Next Century Growth Investors first reported a position in Outset Medical in Q2 2022 and held it in 6 quarters.
  • Next Century Growth Investors's Outset Medical position peaked at $12.4M in Q4 2022.
  • 140 funds tracked by Wall St. Rank held Outset Medical as of Q4 2023.

Based on Next Century Growth Investors's 13F filing for Q4 2023, filed 14 Feb 2024.